STERIS plc (NYSE:STE) Receives $253.00 Consensus PT from Brokerages

STERIS plc (NYSE:STE) has earned a consensus rating of “Moderate Buy” from the six analysts that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $253.00.

A number of research analysts have commented on the company. StockNews.com downgraded STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Piper Sandler raised shares of STERIS from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. KeyCorp boosted their target price on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a research note on Tuesday, September 3rd. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Wednesday, August 7th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Thursday, August 8th.

Insiders Place Their Bets

In related news, CFO Michael J. Tokich sold 23,332 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $247.00, for a total value of $5,763,004.00. Following the completion of the transaction, the chief financial officer now directly owns 42,930 shares of the company’s stock, valued at $10,603,710. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.14% of the stock is owned by insiders.

Institutional Investors Weigh In On STERIS

Several institutional investors have recently bought and sold shares of the stock. Ashton Thomas Securities LLC bought a new position in STERIS during the 3rd quarter valued at $25,000. J.Safra Asset Management Corp lifted its holdings in shares of STERIS by 77.9% in the first quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock valued at $27,000 after buying an additional 53 shares during the period. Central Pacific Bank Trust Division bought a new position in STERIS during the third quarter valued at about $28,000. Quent Capital LLC boosted its stake in STERIS by 112.7% during the first quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 71 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new position in STERIS during the first quarter worth about $36,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Up 0.0 %

Shares of NYSE:STE opened at $227.52 on Monday. STERIS has a 12-month low of $195.47 and a 12-month high of $248.24. The company has a current ratio of 2.33, a quick ratio of 1.49 and a debt-to-equity ratio of 0.35. The firm has a market cap of $22.44 billion, a PE ratio of 56.46 and a beta of 0.85. The company has a fifty day simple moving average of $233.17 and a 200 day simple moving average of $227.60.

STERIS (NYSE:STE) last issued its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.16. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. STERIS had a net margin of 7.36% and a return on equity of 13.85%. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.00 EPS. On average, equities research analysts anticipate that STERIS will post 9.02 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be given a $0.57 dividend. The ex-dividend date is Tuesday, November 19th. This represents a $2.28 annualized dividend and a yield of 1.00%. STERIS’s dividend payout ratio is presently 56.58%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.